Koch, E.A.T.; Petzold, A.; Wessely, A.; Dippel, E.; Gesierich, A.; Gutzmer, R.; Hassel, J.C.; Haferkamp, S.; Kähler, K.C.; Knorr, H.;
et al. Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 2022, 14, 518.
https://doi.org/10.3390/cancers14030518
AMA Style
Koch EAT, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, Haferkamp S, Kähler KC, Knorr H,
et al. Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers. 2022; 14(3):518.
https://doi.org/10.3390/cancers14030518
Chicago/Turabian Style
Koch, Elias A. T., Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Sebastian Haferkamp, Katharina C. Kähler, Harald Knorr,
and et al. 2022. "Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity" Cancers 14, no. 3: 518.
https://doi.org/10.3390/cancers14030518
APA Style
Koch, E. A. T., Petzold, A., Wessely, A., Dippel, E., Gesierich, A., Gutzmer, R., Hassel, J. C., Haferkamp, S., Kähler, K. C., Knorr, H., Kreuzberg, N., Leiter, U., Loquai, C., Meier, F., Meissner, M., Mohr, P., Pföhler, C., Rahimi, F., Schadendorf, D.,
... Heppt, M. V., on behalf of the German Dermatologic Cooperative Oncology Group (DeCOG, Committee Ocular Melanoma).
(2022). Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers, 14(3), 518.
https://doi.org/10.3390/cancers14030518
